TY  - GEN
AU  - Toyota,Joji
AU  - Karino,Yoshiyasu
AU  - Suzuki,Fumitaka
AU  - Ikeda,Fusao
AU  - Ido,Akio
AU  - Tanaka,Katsuaki
AU  - Takaguchi,Koichi
AU  - Naganuma,Atsushi
AU  - Tomita,Eiichi
AU  - Chayama,Kazuaki
AU  - Fujiyama,Shigetoshi
AU  - Inada,Yukiko
AU  - Yoshiji,Hitoshi
AU  - Watanabe,Hideaki
AU  - Ishikawa,Hiroki
AU  - Hu,Wenhua
AU  - McPhee,Fiona
AU  - Linaberry,Misti
AU  - Yin,Philip D
AU  - Swenson,Eugene Scott
AU  - Kumada,Hiromitsu
TI  - Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection
SN  - 1435-5922
PY  - 2017///0905
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Benzazepines
KW  - Carbamates
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Imidazoles
KW  - Indoles
KW  - Isoquinolines
KW  - Liver Cirrhosis
KW  - virology
KW  - Male
KW  - Middle Aged
KW  - Pyrrolidines
KW  - RNA, Viral
KW  - blood
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Outcome
KW  - Valine
KW  - analogs & derivatives
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s00535-016-1245-6
ER  -